Neil Garry Arthur

Avalo Therapeutics, Inc. · Chief Executive Officer

Neil Garry Arthur is listed in public filings as director, officer: Chief Executive Officer. This Neil Garry Arthur insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Avalo Therapeutics, Inc. (AVTX), and Celldex Therapeutics, Inc. (CLDX). Investors use Neil Garry Arthur's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX--190.3k sharesGrant / ExerciseMay 21, 2026Disclosure amount unavailable100.2k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Avalo Therapeutics, Inc.AVTX$1.3M90.1k sharesGrant / ExerciseMar 28, 2026$304.1K21.9k shares$13.89--
Avalo Therapeutics, Inc.AVTX--64.9k sharesGrant / ExerciseMar 28, 2026Disclosure amount unavailable64.9k shares----
Avalo Therapeutics, Inc.AVTX$5.0M286k sharesGrant / ExerciseFeb 26, 2026$5.0M286k shares$17.64--
Celldex Therapeutics, Inc.CLDX$322k16.5k sharesGrant / ExerciseJun 5, 2025$322.2K16.5k shares$19.53--
Avalo Therapeutics, Inc.AVTX--64.9k sharesGrant / ExerciseMar 28, 2025Disclosure amount unavailable64.9k shares----
Avalo Therapeutics, Inc.AVTX$399k47.1k sharesGrant / ExerciseMar 28, 2025$150.5K17.8k shares$8.46--
Avalo Therapeutics, Inc.AVTX$3.3M411k sharesGrant / ExerciseJan 28, 2025$3.3M411k shares$8.04--
Avalo Therapeutics, Inc.AVTX$4.9M500.4k sharesGrant / ExerciseAug 13, 2024$4.9M500.4k shares$9.88--
Avalo Therapeutics, Inc.AVTX--194.6k sharesGrant / ExerciseAug 13, 2024Disclosure amount unavailable194.6k shares----
Celldex Therapeutics, Inc.CLDX$601k16.5k sharesGrant / ExerciseJun 13, 2024$601.1K16.5k shares$36.43--